Skip to content

Integra LifeSciences IART Tissue Reconstruction — Cost of goods sold

Other segment segments

Specialty Surgery
$110.48M

Similar metrics at other companies

Enovis logo
ENOVReconstructive — Cost of Goods Sold
$97.34M+0.1%
Enovis logo
ENOVReconstructive — Operating Costs and Expenses
$270.4M+6.1%
Enovis logo
ENOVReconstructive — Other Cost and Expense, Operating
$149.28M+7.9%
Inspire Medical Systems logo
INSPOperating Segment — Cost of goods sold
$27.67M-9.9%
Enovis logo
ENOVReconstructive — Net Sales
$317.13M+10.8%
Enovis logo
ENOVPrevention & Recovery — Cost of Goods Sold
$125.76M-2.3%

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B+53.4%
Enterprise value$3.12B+21.1%
P/S0.8×+0.3×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's tissue reconstruction — cost of goods sold.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's tissue reconstruction — cost of goods sold?
Integra LifeSciences (IART) reported tissue reconstruction — cost of goods sold of $37.46M in Q1 2026.
What does tissue reconstruction — cost of goods sold mean?
This represents the direct costs attributable to the production and manufacturing of products within the Tissue Reconstruction segment. Monitoring this metric is essential for evaluating the segment's gross margin efficiency and production cost management.